Cargando…
Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for Care
Spinal Muscular Atrophy (SMA) is caused by autosomal recessive mutations in SMN1 and results in the loss of motor neurons and progressive muscle weakness. The spectrum of disease severity ranges from early onset with respiratory failure during the first months of life to a mild, adult-onset type wit...
Autores principales: | Schorling, David C., Pechmann, Astrid, Kirschner, Janbernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029319/ https://www.ncbi.nlm.nih.gov/pubmed/31707373 http://dx.doi.org/10.3233/JND-190424 |
Ejemplares similares
-
SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy
por: Pechmann, Astrid, et al.
Publicado: (2019) -
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study
por: Kiefer, Petra, et al.
Publicado: (2020) -
New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges
por: Messina, Sonia, et al.
Publicado: (2020) -
Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey
por: Schorling, David C., et al.
Publicado: (2020) -
Mechanographic analysis of the timed 4 stair climb test – methodology and reference data of healthy children and adolescents
por: Schorling, David C., et al.
Publicado: (2023)